L-005-2025
Agreement ID
L-005-2025
Lead IC
NCI
Exclusivity
Exclusive
External Party
Iovance Biotherapeutics. Inc.
Fiscal Year
2026
Territory
Worldwide
Execution Date
Effective Date
Export Date